| NCT ID | NCT05693857 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Patient-Perceived Versus |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2023-06-11 |
| Primary Completion | 2028-02-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2023-06-11 with a primary completion date of 2028-02-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiovascular prevention guidelines use estimated 10-year atherosclerotic cardiovascular disease (ASCVD) risk to guide treatment decisions and engage patients in shared decision-making. Research has focused on refining the accuracy of these CV risk calculators for different populations, relatively little has been done to understand how patients perceive their own ASCVD risk. Accurate perception of a patient's risk by both the patient and the doctors is important because this is an important determinant of health-related behaviour. Patients often show optimistic bias when considering their own CV risk and consistently underestimate it. We aim to determine patient perceived versus actual risk of ASCVD in a Chinese population. We aim to better understand the degree to which patients underestimate or overestimate their ASCVD risk and whether patients are better or worse at estimating their ASCVD risk relative to their peers of the same age and sex. Finally, we aim to evaluate patients willingness to follow guideline recommended CV prevention and specifically lipid-lowering therapy.
Eligibility Criteria
Inclusion Criteria: 1. Aged 40 years and above 2. Consent to complete questionnaire 3. Lipid profile within 12 months Exclusion Criteria: 1. Known ASCVD defined as history of coronary heart disease (i.e. obstructive coronary disease, prior myocardial infarction, or prior coronary revascularization); cerebrovascular disease (i.e. stroke or transient ischemic attack); and peripheral arterial disease (i.e. obstructive peripheral disease, prior vascular amputation or prior revascularization) 2. Other chronic illness with life-expectancy \<12 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05693857 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 90 Years, studying Patient-Perceived Versus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05693857 currently recruiting?
Yes, NCT05693857 is actively recruiting participants. Contact the research team at danielxu@cuhk.edu.hk for enrollment information.
Where is the NCT05693857 trial being conducted?
This trial is being conducted at Shatin, Hong Kong.
Who is sponsoring the NCT05693857 clinical trial?
NCT05693857 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 1,500 participants.